Tag Archives: Advanced

Black Men With Advanced Prostate Cancer Live Longer Thanks to New Hormone Therapies

Prostate cancer has historically been more common, more aggressive and more lethal in African-American men compared with other racial groups. But new findings presented at the 2019 Genitourinary Cancers Symposium reveal that Black men with advanced prostate cancer treated with newer hormone therapies lived 20 percent longer than their white counterparts, reports the American Society… Read More »

Lynparza (olaparib) Approved by US FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer

Print this page 19 December 2018 — AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved Lynparza for use as maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm)… Read More »